ARTICLE | Clinical News
Mylotarg gemtuzumab zogamicin regulatory update
November 20, 2000 8:00 AM UTC
The European Commission granted orphan medicinal product designation to the partners' Mylotarg, a humanized antibody against CD33 linked to the calicheamicin cytotoxin, to treat CD33-positive relapse...